Perspective Therapeutics CFO Hunt becomes sole principal financial officer; VP Austin departs

Perspective Therapeutics, Inc.

Mark Austin ceased as VP of Finance, Corporate Controller, Corporate Secretary, and co-principal financial officer on August 16, 2024.
CFO Jonathan Hunt (age 57) now serves as sole principal financial officer and principal accounting officer.
No arrangements, family relationships, or interested transactions exist between Hunt and the company or its officers.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Jonathan Hunt

Chief Financial Officer

CATX · Perspective Therapeutics, Inc.

Effective: 2024-08-16
Filed: August 19, 2024, 7:59 PM ET

Effective as of the Effective Date, Jonathan Hunt, the Company’s Chief Financial Officer and “co-principal financial officer,” began serving as the Company’s sole “principal financial officer” and “principal accounting officer.”

Departed

Mark Austin

Vice President of Finance, Corporate Controller and Corporate Secretary

CATX · Perspective Therapeutics, Inc.

Effective: 2024-08-16
Successor: Jonathan Hunt
Filed: August 19, 2024, 7:59 PM ET

On August 16, 2024 (the “ Effective Date ”), Mark Austin, the Vice President of Finance, Corporate Controller and Corporate Secretary of Perspective Therapeutics, Inc. (the “ Company ”), ceased serving as an executive officer and as the Company’s “co-principal financial officer” and “principal accounting officer.”

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jonathan Hunt changed role as Chief Financial Officer at Perspective Therapeutics, Inc..

Action: designated
Role: Chief Financial Officer

Exact text from the filing

Effective as of the Effective Date, Jonathan Hunt, the Company’s Chief Financial Officer and “co-principal financial officer,” began serving as the Company’s sole “principal financial officer” and “principal accounting officer.”

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Mark Austin resigned as Vice President of Finance, Corporate Controller and Corporate Secretary at Perspective Therapeutics, Inc..

Action: resigned
Role: Vice President of Finance, Corporate Controller and Corporate Secretary

Exact text from the filing

On August 16, 2024 (the “ Effective Date ”), Mark Austin, the Vice President of Finance, Corporate Controller and Corporate Secretary of Perspective Therapeutics, Inc. (the “ Company ”), ceased serving as an executive officer and as the Company’s “co-principal financial officer” and “principal accounting officer.”

View on SEC.gov

Perspective Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-24-098685

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.